Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Theseus Pharmaceuticals Inc (NQ: THRX )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Feb 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 4.060 (3)
Ask (Size) 4.070 (1)
Prev. Close 4.060
Today's Range N/A - N/A
52wk Range 2.050 - 4.200
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
THESEUS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Theseus Pharmaceuticals, Inc. - THRX
From Kahn Swick & Foti, LLC
Via Business Wire
Small-Cap Cancer Focused Theseus Pharmaceuticals Goes Private For Over $3.90/Share In Cash
Theseus Pharmaceuticals Inc (NASDAQ: THRX) on Friday, has entered into a definitive merger agreement whereby Concentra Biosciences LLC will acquire Theseus for a price per share of between $3.90 and... 
Via Benzinga

Performance

More News

Read More
THRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Theseus Pharmaceuticals, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Dow Jumps Over 500 Points; Home Depot Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
Crude Oil Moves Higher; Beauty Health Shares Plunge
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Nasdaq Surges 2%; US Inflation Rate Slows In October
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Deciphera Pharmaceuticals Sees Renewed Competitive Edge After Theseus Pan-KIT Discontinuation: Analyst
Via Benzinga
Why Infosys Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
$2M Bet On Molecular Templates? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
Via Benzinga
Nasdaq Drops 50 Points; Wells Fargo Earnings Beat Views
Via Benzinga
Setback For Theseus Pharmaceuticals: Analysts Cut Price Targets But Remain Bullish On Stock
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Crude Oil Down 2%; Citigroup Profit Tops Estimates
Via Benzinga
Why State Street Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Dow Jumps 150 Points; JPMorgan Posts Upbeat Earnings
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023
Via Benzinga
PLUG Stock Alert: Plug Power Pops on Analyst Upgrade
Via InvestorPlace
Dose-Limiting Toxicities: Theseus Pharma Terminates THE-630 Study For Gastrointestinal Cancer
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.